Search - tctmd.com

Displaying 481 - 500 of 699

Sort: Relevancy | Date

Presentation Fellows 2015

Renal Artery Interventions: Current State of the Field

Presenter: William A. Gray, Duane S. Pinto

May 17, 2015

Presentation ARCH 2015

Renal Denervaton ~ Early Trials

Presenter: Rothstein Marcos

April 11, 2015

Presentation ARCH 2015

Renal Artery Revascularization

Presenter: Marc A. Sintek

April 09, 2015

Presentation CADECI 2015

Donde estamos en la denervación renal, después del estudio SYMPLICITY 3

Presenter: Dr. Juan Gaspar

February 19, 2015

Presentation ISET 2015

Is There a Role for Renal Stenting in 2015?

Presenter: Jeffrey W. Olin

February 03, 2015

Presentation ISET 2015

Is There Hope for Renal Denervation?

Presenter: Ron Waksman

February 01, 2015

Presentation ISET 2015

Current Challenge and Directions in Renal Denervation

Presenter: Marty B. Leon

February 01, 2015

Presentation

Randomized Comparison of Renal Denervation vs Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension

Presenter: J?n Rosa

December 04, 2014

Presentation

Postprocedural Hemodiafiltration in ACS Patients With Renal and Cardiac Dysfunction Undergoing Urgent, Emergent Coronary Angiography

Presenter: Giancarlo Marenzi

November 02, 2014

Presentation VEINS 2014

Role of Supra Renal IVC Filters and SVC Filters

Presenter: Matthew S. Johnson

October 12, 2014

Presentation VEINS 2014

Renal, Mesenteric, and Aortic Duplex

Presenter: Heather L. Gornik

October 09, 2014

Presentation TCT 2014

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston

September 16, 2014

Presentation TCT 2014

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka

September 16, 2014

Presentation TCT 2014

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Felix Mahfoud

September 16, 2014

Presentation TCT 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Presenter: George D. Dangas, Michael E. Farkouh, Usman Baber

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

Presentation TCT 2014

CON Problematic and Challenged

Presenter: Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

PRO Continued Optimism

Presenter: Felix Mahfoud

September 16, 2014

Advertisement

Renal Artery Interventions: Current State of the Field

Renal Denervaton ~ Early Trials

Renal Artery Revascularization

Donde estamos en la denervación renal, después del estudio SYMPLICITY 3

Is There a Role for Renal Stenting in 2015?

Is There Hope for Renal Denervation?

Current Challenge and Directions in Renal Denervation

Randomized Comparison of Renal Denervation vs Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension

Postprocedural Hemodiafiltration in ACS Patients With Renal and Cardiac Dysfunction Undergoing Urgent, Emergent Coronary Angiography

Role of Supra Renal IVC Filters and SVC Filters

Renal, Mesenteric, and Aortic Duplex

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Clinical Trial Updates: RenalGuard, AVERT, etc.

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

CON Problematic and Challenged

PRO Continued Optimism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content